Although the human proclivity to engage in impression management and care for reputation is ubiquitous, the question of its developmental outset remains open. In 4 studies, we demonstrate that the sensitivity to the evaluation of others (i.e., evaluative audience perception) is manifest by 24 months. In a first study, 14- to 24-month-old children (N = 49) were tested in situations in which the attention of an audience was systematically manipulated. Results showed that when the experimenter was inattentive, as opposed to attentive, children were more likely to explore an attractive toy. A second study (N = 31) explored whether same-aged children would consider not only the attention of the experimenter but also the values the experimenter expressed for two different outcomes when exploring a toy. We found that children reproduced outcomes that were positively valued by the experimenter significantly more when the experimenter was attentive but were more likely to reproduce negatively valued outcomes when the experimenter was inattentive. A third control study (N = 30) showed that the significant effect of Study 2 disappeared in the absence of different values. Lastly, Study 4 (N = 34) replicated and extended the phenomenon by showing toddler's propensity to modify their behavior in the presence of 2 different experimenters, depending on both the experimenter's evaluation of an outcome and their attention. Overall, these data provide the first convergent demonstration of evaluative audience perception in young children that precedes the full-fledged normative, mentalizing, and strong conformity psychology documented in 4- to 5-year-old children. (PsycINFO Database Record
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1037/dev0000548 | DOI Listing |
J Ovarian Res
January 2025
Department of Medical Genetics, National Taiwan University Hospital, 19F, No. 8, Chung-Shan South Road, Taipei City, Taiwan.
Background: The homologous recombination deficiency (HRD) test is an important tool for identifying patients with epithelial ovarian cancer (EOC) benefit from the treatment with poly(adenosine diphosphate-ribose) polymerase inhibitor (PARPi). Using whole exome sequencing (WES)-based platform can provide information of gene mutations and HRD score; however, the clinical value of WES-based HRD test was less validated in EOC.
Methods: We enrolled 40 patients with EOC in the training cohort and 23 in the validation cohort.
AIDS Res Ther
January 2025
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
The global HIV epidemic remains a major public health challenge, with DTG playing a key role in ART regimens due to its efficacy and tolerability. This study evaluated virological outcomes and resistance mutations in patients on DTG in Mozambique through a retrospective cohort study in seven DREAM centers. Data from 29,601 patients (98.
View Article and Find Full Text PDFJ Ovarian Res
January 2025
Department of Health Education, Nanjing Municipal Center for Disease Control and Prevention, No.3, Zizhulin Road, Nanjing, Jiangsu Province, 210003, China.
Background: PARP inhibitors (PARPis) have shown promising effectiveness for ovarian cancer. This network meta-analysis (PROSPERO registration number CRD42024503390) comprehensively evaluated the effectiveness and safety of PARPis in platinum-sensitive recurrent ovarian cancer (PSROC).
Methods: Articles published before January 6, 2024 were obtained from electronic databases.
J Transl Med
January 2025
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Background: HER2-targeted therapies have revolutionized the treatment of HER2-positive breast cancer patients, leading to significant improvements in tumor response rates and survival. However, resistance and incomplete response remain considerable challenges. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition is a novel therapeutic strategy for the management of dyslipidemia by enhancing the clearance of low-density lipoprotein cholesterol receptors, however recent evidence also shows links between PCSK9 and cancer cells.
View Article and Find Full Text PDFBMC Vet Res
January 2025
Technology Center, Hohhot Customs District, Hohhot, 010020, Inner Mongolia, China.
Background: Bovine viral diarrhoea virus genotype 1 (BVDV-1) and bluetongue virus (BTV) are potent viral pathogens that may be transmitted through semen, resulting in the spread of diseases via artificial insemination. Thus, establishing an early detection method for BVDV-1 and BTV infection is important for the trading of semen. In this study, we developed two RT‒ddPCR methods to detect BVDV-1 and BTV, and each method was evaluated for repeatability, limit of detection and specificity.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!